These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25978392)

  • 41. [Comparative substrate-inhibitor analysis of liver monoamine oxidases of minks].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2010; 46(5):380-6. PubMed ID: 21061647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromenylchalcones with inhibitory effects on monoamine oxidase B.
    Jo G; Ahn S; Kim BG; Park HR; Kim YH; Choo HA; Koh D; Chong Y; Ahn JH; Lim Y
    Bioorg Med Chem; 2013 Dec; 21(24):7890-7. PubMed ID: 24169316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.
    Geldenhuys WJ; Funk MO; Van der Schyf CJ; Carroll RT
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1380-3. PubMed ID: 22225638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors.
    Braun GH; Jorge DM; Ramos HP; Alves RM; da Silva VB; Giuliatti S; Sampaio SV; Taft CA; Silva CH
    J Biomol Struct Dyn; 2008 Feb; 25(4):347-55. PubMed ID: 18092829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Jan; 19(1):261-74. PubMed ID: 21134756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. cis-Cyclopropylamines as mechanism-based inhibitors of monoamine oxidases.
    Malcomson T; Yelekci K; Borrello MT; Ganesan A; Semina E; De Kimpe N; Mangelinckx S; Ramsay RR
    FEBS J; 2015 Aug; 282(16):3190-8. PubMed ID: 25755053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular docking of inhibitors into monoamine oxidase B.
    Harkcom WT; Bevan DR
    Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular aspects of monoamine oxidase B.
    Ramsay RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():81-9. PubMed ID: 26891670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
    Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
    Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues.
    Mostert S; Mentz W; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2012 Dec; 20(24):7040-50. PubMed ID: 23122934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
    Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
    J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
    Tripathi RK; Goshain O; Ayyannan SR
    ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].
    Ramsay RR
    Vopr Med Khim; 1997; 43(6):457-70. PubMed ID: 9503563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
    Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
    Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening.
    Shelke SM; Bhosale SH; Dash RC; Suryawanshi MR; Mahadik KR
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2419-24. PubMed ID: 21397504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F
    Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of monoamine oxidase by phthalide analogues.
    Strydom B; Bergh JJ; Petzer JP
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1269-73. PubMed ID: 23374869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.